Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Bacteriol ; 201(11)2019 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-30858300

RESUMEN

Korormicin is an antibiotic produced by some pseudoalteromonads which selectively kills Gram-negative bacteria that express the Na+-pumping NADH:quinone oxidoreductase (Na+-NQR.) We show that although korormicin is an inhibitor of Na+-NQR, the antibiotic action is not a direct result of inhibiting enzyme activity. Instead, perturbation of electron transfer inside the enzyme promotes a reaction between O2 and one or more redox cofactors in the enzyme (likely the flavin adenine dinucleotide [FAD] and 2Fe-2S center), leading to the production of reactive oxygen species (ROS). All Pseudoalteromonas contain the nqr operon in their genomes, including Pseudoalteromonas strain J010, which produces korormicin. We present activity data indicating that this strain expresses an active Na+-NQR and that this enzyme is not susceptible to korormicin inhibition. On the basis of our DNA sequence data, we show that the Na+-NQR of Pseudoalteromonas J010 carries an amino acid substitution (NqrB-G141A; Vibrio cholerae numbering) that in other Na+-NQRs confers resistance against korormicin. This is likely the reason that a functional Na+-NQR is able to exist in a bacterium that produces a compound that typically inhibits this enzyme and causes cell death. Korormicin is an effective antibiotic against such pathogens as Vibrio cholerae, Aliivibrio fischeri, and Pseudomonas aeruginosa but has no effect on Bacteroides fragilis and Bacteroides thetaiotaomicron, microorganisms that are important members of the human intestinal microflora.IMPORTANCE As multidrug antibiotic resistance in pathogenic bacteria continues to rise, there is a critical need for novel antimicrobial agents. An essential requirement for a useful antibiotic is that it selectively targets bacteria without significant effects on the eukaryotic hosts. Korormicin is an excellent candidate in this respect because it targets a unique respiratory enzyme found only in prokaryotes, the Na+-pumping NADH:quinone oxidoreductase (Na+-NQR). Korormicin is synthesized by some species of the marine bacterium Pseudoalteromonas and is a potent and specific inhibitor of Na+-NQR, an enzyme that is essential for the survival and proliferation of many Gram-negative human pathogens, including Vibrio cholerae and Pseudomonas aeruginosa, among others. Here, we identified how korormicin selectively kills these bacteria. The binding of korormicin to Na+-NQR promotes the formation of reactive oxygen species generated by the reaction of the FAD and the 2Fe-2S center cofactors with O2.


Asunto(s)
Antibacterianos/farmacología , Antibiosis , Pseudoalteromonas/metabolismo , Especies Reactivas de Oxígeno/agonistas , Aliivibrio fischeri/efectos de los fármacos , Aliivibrio fischeri/enzimología , Aliivibrio fischeri/crecimiento & desarrollo , Aliivibrio fischeri/patogenicidad , Antibacterianos/metabolismo , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Bacteroides fragilis/efectos de los fármacos , Bacteroides fragilis/enzimología , Bacteroides fragilis/crecimiento & desarrollo , Bacteroides thetaiotaomicron/efectos de los fármacos , Bacteroides thetaiotaomicron/enzimología , Bacteroides thetaiotaomicron/crecimiento & desarrollo , Ácidos Grasos Insaturados/biosíntesis , Ácidos Grasos Insaturados/farmacología , Flavina-Adenina Dinucleótido/metabolismo , Expresión Génica , Lactonas/farmacología , Pruebas de Sensibilidad Microbiana , Modelos Moleculares , Operón , Oxidación-Reducción , Estructura Secundaria de Proteína , Pseudoalteromonas/genética , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/enzimología , Pseudomonas aeruginosa/crecimiento & desarrollo , Pseudomonas aeruginosa/patogenicidad , Quinona Reductasas/antagonistas & inhibidores , Quinona Reductasas/genética , Quinona Reductasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , ATPasa Intercambiadora de Sodio-Potasio/genética , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Vibrio cholerae/efectos de los fármacos , Vibrio cholerae/enzimología , Vibrio cholerae/crecimiento & desarrollo , Vibrio cholerae/patogenicidad
2.
Biochemistry ; 58(13): 1728-1737, 2019 04 02.
Artículo en Inglés | MEDLINE | ID: mdl-30835452

RESUMEN

Commensal bacteria secrete proteins and metabolites to influence host intestinal homeostasis, and proteases represent a significant constituent of the components at the host:microbiome interface. Here, we determined the structures of the two secreted C11 cysteine proteases encoded by the established gut commensal Bacteroides thetaiotaomicron. We employed mutational analysis to demonstrate the two proteases, termed "thetapain" and "iotapain", undergo in trans autoactivation after lysine and/or arginine residues, as observed for other C11 proteases. We determined the structures of the active forms of thetapain and iotapain in complex with irreversible peptide inhibitors, Ac-VLTK-AOMK and biotin-VLTK-AOMK, respectively. Structural comparisons revealed key active-site interactions important for peptide recognition are more extensive for thetapain; however, both proteases employ a glutamate residue to preferentially bind small polar residues at the P2 position. Our results will aid in the design of protease-specific probes to ultimately understand the biological role of C11 proteases in bacterial fitness, elucidate their host and/or microbial substrates, and interrogate their involvement in microbiome-related diseases.


Asunto(s)
Bacteroides thetaiotaomicron/enzimología , Proteasas de Cisteína/química , Inhibidores de Cisteína Proteinasa/farmacología , Péptidos/farmacología , Infecciones por Bacteroides/microbiología , Bacteroides thetaiotaomicron/química , Bacteroides thetaiotaomicron/efectos de los fármacos , Bacteroides thetaiotaomicron/metabolismo , Dominio Catalítico/efectos de los fármacos , Cristalografía por Rayos X , Proteasas de Cisteína/metabolismo , Humanos , Simulación del Acoplamiento Molecular , Conformación Proteica/efectos de los fármacos
3.
Artículo en Inglés | MEDLINE | ID: mdl-28484684

RESUMEN

Enterohemorrhagic Escherichia coli (EHEC) O157:H7 are human pathogens responsible for bloody diarrhea and renal failures. EHEC employ a type 3 secretion system to attach directly to the human colonic epithelium. This structure is encoded by the locus of enterocyte effacement (LEE) whose expression is regulated in response to specific nutrients. In this study, we show that the mucin-derived sugars N-acetylglucosamine (NAG) and N-acetylneuraminic acid (NANA) inhibit EHEC adhesion to epithelial cells through down-regulation of LEE expression. The effect of NAG and NANA is dependent on NagC, a transcriptional repressor of the NAG catabolism in E. coli. We show that NagC is an activator of the LEE1 operon and a critical regulator for the colonization of mice intestine by EHEC. Finally, we demonstrate that NAG and NANA as well as the metabolic activity of Bacteroides thetaiotaomicron affect the in vivo fitness of EHEC in a NagC-dependent manner. This study highlights the role of NagC in coordinating metabolism and LEE expression in EHEC and in promoting EHEC colonization in vivo.


Asunto(s)
Acetilglucosamina/antagonistas & inhibidores , Adhesión Bacteriana/efectos de los fármacos , Escherichia coli Enterohemorrágica/genética , Proteínas de Escherichia coli/genética , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Fosfoproteínas/genética , Proteínas Represoras/genética , Animales , Bacteroides thetaiotaomicron/efectos de los fármacos , Línea Celular , Modelos Animales de Enfermedad , Escherichia coli Enterohemorrágica/metabolismo , Escherichia coli Enterohemorrágica/patogenicidad , Células Epiteliales/microbiología , Escherichia coli O157/genética , Escherichia coli O157/metabolismo , Proteínas de Escherichia coli/metabolismo , Proteínas de Escherichia coli/fisiología , Células HCT116 , Células HeLa , Humanos , Intestinos/microbiología , Ratones , Ratones Endogámicos BALB C , Mutación , Ácido N-Acetilneuramínico/antagonistas & inhibidores , Operón , Fosfoproteínas/metabolismo , Proteínas Represoras/fisiología
4.
PLoS One ; 11(9): e0162604, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27612304

RESUMEN

The aging process leads to alterations of gut microbiota and modifications to the immune response, such changes may be associated with increased disease risk. Prebiotics and probiotics can modulate microbiome changes induced by aging; however, their effects have not been directly compared. The aim of this study was to use anaerobic batch culture fermenters to assess the impact of various fermentable carbohydrates and microorganisms on the gut microbiota and selected immune markers. Elderly volunteers were used as donors for these experiments to enable relevance to an aging population. The impact of fermentation supernatants on immune markers relevant to the elderly were assessed in vitro. Levels of IL-1ß, IL-6, IL-8, IL-10 and TNF-α in peripheral blood mononuclear cell culture supernatants were measured using flow cytometry. Trans-galactooligosaccharides (B-GOS) and inulin both stimulated bifidobacteria compared to other treatments (p<0.05). Fermentation supernatants taken from faecal batch cultures supplemented with B-GOS, inulin, B. bifidum, L. acidophilus and Ba. coagulans inhibited LPS induced TNF-α (p<0.05). IL-10 production, induced by LPS, was enhanced by fermentation supernatants from faecal batch cultures supplemented with B-GOS, inulin, B. bifidum, L. acidophilus, Ba. coagulans and Bac. thetaiotaomicron (p<0.05). To conclude, prebiotics and probiotics could lead to potentially beneficial effects to host health by targeting specific bacterial groups, increasing saccharolytic fermentation and decreasing inflammation associated with aging. Compared to probiotics, prebiotics led to greater microbiota modulation at the genus level within the fermenters.


Asunto(s)
Heces/microbiología , Prebióticos/microbiología , Probióticos/farmacología , Anciano , Bacillus coagulans/efectos de los fármacos , Bacillus coagulans/fisiología , Bacteroides thetaiotaomicron/efectos de los fármacos , Bacteroides thetaiotaomicron/fisiología , Bifidobacterium bifidum/efectos de los fármacos , Bifidobacterium bifidum/fisiología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Fermentación , Humanos , Hibridación Fluorescente in Situ , Interleucina-10/metabolismo , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/efectos de los fármacos , Microbiota/efectos de los fármacos , Persona de Mediana Edad , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA